Yuncheng Li

860 total citations
45 papers, 546 citations indexed

About

Yuncheng Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yuncheng Li has authored 45 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Yuncheng Li's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (7 papers) and Head and Neck Cancer Studies (5 papers). Yuncheng Li is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (7 papers) and Head and Neck Cancer Studies (5 papers). Yuncheng Li collaborates with scholars based in China, United States and United Kingdom. Yuncheng Li's co-authors include Weijia Kong, Sulin Zhang, Zhengang Tang, Feng Pan, Yu Hu, Chuansheng Zheng, Bo Liang, Lian Yang, Lingli Li and Li Lin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Yuncheng Li

40 papers receiving 540 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yuncheng Li 215 171 136 120 74 45 546
Wei Qi 313 1.5× 239 1.4× 178 1.3× 81 0.7× 104 1.4× 20 650
Shuang Yao 190 0.9× 157 0.9× 99 0.7× 105 0.9× 24 0.3× 58 642
Ze‐Xiao Lin 196 0.9× 234 1.4× 126 0.9× 181 1.5× 105 1.4× 23 693
Zheyi Han 317 1.5× 309 1.8× 282 2.1× 73 0.6× 151 2.0× 14 749
Chuanwu Zhu 158 0.7× 146 0.9× 82 0.6× 110 0.9× 32 0.4× 69 643
Sean K. Maden 265 1.2× 314 1.8× 68 0.5× 67 0.6× 70 0.9× 14 657
Mohammed Bouziane 353 1.6× 145 0.8× 65 0.5× 117 1.0× 14 0.2× 75 608
Lei Yuan 146 0.7× 122 0.7× 55 0.4× 44 0.4× 21 0.3× 46 635
Ronghua Xu 203 0.9× 102 0.6× 77 0.6× 81 0.7× 13 0.2× 28 482
Venice Chávez‐Valencia 156 0.7× 138 0.8× 32 0.2× 47 0.4× 70 0.9× 18 407

Countries citing papers authored by Yuncheng Li

Since Specialization
Citations

This map shows the geographic impact of Yuncheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuncheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuncheng Li more than expected).

Fields of papers citing papers by Yuncheng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuncheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuncheng Li. The network helps show where Yuncheng Li may publish in the future.

Co-authorship network of co-authors of Yuncheng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yuncheng Li. A scholar is included among the top collaborators of Yuncheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuncheng Li. Yuncheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Groppelli, Elisabetta, Clemens Grünwald‐Gruber, Huimin Hu, et al.. (2024). Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2. Molecular Therapy. 32(3). 689–703. 13 indexed citations
3.
Li, Yuncheng, et al.. (2023). Case report: Obstructive jaundice caused by biliary cystadenoma. Frontiers in Oncology. 13. 1165979–1165979.
4.
Hori, Naoto, Hiroshi Tazawa, Yuncheng Li, et al.. (2023). Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells. Anticancer Research. 43(11). 4809–4821. 2 indexed citations
6.
Tazawa, Hiroshi, Naoto Hori, Yuncheng Li, et al.. (2023). p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells. PLoS ONE. 18(11). e0294491–e0294491. 5 indexed citations
7.
Hu, Huimin, et al.. (2022). Herpes simplex virus type 2 inhibits TNF-α-induced NF-κB activation through viral protein ICP22-mediated interaction with p65. Frontiers in Immunology. 13. 983502–983502. 1 indexed citations
8.
Song, Yang, Yan Sun, Ye Tao, et al.. (2020). IL‐17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer via the Inhibition of Apoptosis through Activation of the PI3K/AKT/FAS/FASL Pathways. Journal of Immunology Research. 2020(1). 2953191–2953191. 21 indexed citations
9.
Wang, Xiangming, Chao Zhang, Wenbin Yu, et al.. (2020). <p>Risk Factors That Influence Surgical Decision-Making for Patients with Low-Risk Differentiated Thyroid Cancer with Tumor Diameters of 1–4 cm</p>. Cancer Management and Research. Volume 12. 12423–12428. 3 indexed citations
10.
Liu, Chuan, Neil D. Gross, Guojun Li, et al.. (2020). PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells. Journal of Cellular and Molecular Medicine. 24(4). 2444–2450. 14 indexed citations
11.
Lu, Wenjie, Rukun Zang, Xinghua Li, et al.. (2020). <p>Overexpression of <em>MTFR2</em> Predicts Poor Prognosis of Breast Cancer</p>. Cancer Management and Research. Volume 12. 11095–11102. 8 indexed citations
12.
Chen, Hao, Hengyu Li, Yuncheng Li, et al.. (2018). Clinical and imaging characteristics of subacute combined degeneration complicated with white matter lesions in the brain: a report of five cases. Somatosensory & Motor Research. 35(2). 119–123. 5 indexed citations
13.
Zhang, Jianjing, et al.. (2017). Risk factors for mortality in patients with severe fever with thrombocytopenia syndrome. 35(6). 336–340. 3 indexed citations
14.
Li, Yuncheng, et al.. (2017). Nodular fasciitis of the face: A case report and review of the literature. 10(1). 1443–1445.
15.
Zhang, Yang, Erich M. Sturgis, Yuncheng Li, et al.. (2017). Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx. Scientific Reports. 7(1). 39765–39765. 4 indexed citations
16.
Wang, Shuqin, Yuncheng Li, Guojun Li, & Lijun Zhu. (2016). Mammary analogue secretory carcinoma presenting as a salivary gland neoplasm: A first clinical case report of an exceptionally rare tumor in China. 9(11). 22632–22637. 3 indexed citations
17.
Li, Yuncheng, Erich M. Sturgis, Lijun Zhu, et al.. (2016). E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx. Molecular Carcinogenesis. 56(4). 1335–1343. 12 indexed citations
18.
Chen, Jian, Sulin Zhang, Yuncheng Li, Zhengang Tang, & Weijia Kong. (2013). Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma. Tumor Biology. 35(4). 3743–3753. 60 indexed citations
19.
Li, Shibo, et al.. (2012). Protective effects of ursodeoxycholic acid on α-naphthylisothi-induced acute liver injury in rats. Zhonghua xiaohua zazhi. 32(5). 325–329. 1 indexed citations
20.
Li, Yuncheng, et al.. (2006). Iodine-catalyzed Synthesis of α-Amino Phosphonates. Chinese Chemical Letters. 17(6). 733–735. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026